Company

Investment-firm

Financing round

General

About Company
Hx Bio Ventures invests in early-stage biotech companies developing next-gen biologics.

Industry

Sector :

Subsector :

Keywords :

IPO status

Private

Description

Hx Bio Ventures partners with innovative biotech startups to support their drug development and manufacturing processes, helping them mitigate risks in the early stages. Their focus and expertise lie in the field of next-generation biologics, enabling them to assist exceptional entrepreneurs in building the next wave of successful biotech companies.
Contacts
Similar Companies
311
Tellus BioVentures

Tellus BioVentures

Tellus BioVentures is a Florida-based biotech venture capital firm.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

count Of Investments

12
Biotechonomy

Biotechonomy

Biotechonomy invests in innovative biotech start-ups and early-stage companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Boston, MA, USA

count Of Investments

1

Biotechnology Development Fund VI, L.P.

Biotech Development Fund IV invests in late-stage healthcare and biotech companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Palo Alto, CA, USA

count Of Investments

3

count Of Exists

1
BiovelocITA

BiovelocITA

BiovelocITA is an Italian company that accelerates early-stage biotech projects.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Milan, Metropolitan City of Milan, Italy

total rounds

2

total raised

$15.51M

count Of Investments

2

Financials

Investments
1
Date 
name 
Lead 
type 
Raised 
14.10.2021
No
$26.74M
Local Amount - EUR 31M
Abalos Therapeutics

Abalos Therapeutics

Abalos Therapeutics is a company developing a novel immuno-virotherapy to fight cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Essen, Germany

total rounds

2

total raised

$39.98M
Co-Investors

Activity

Recent News
0